ArticleTherapeutic advances in medical oncology2018

Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer.

Po-Lan Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.